Global Anti-Viral Drugs
This presentation is the property of its rightful owner.
Sponsored Links
1 / 7

Anti-Viral Drugs Market Value Share, Supply Demand, share and Value Chain 2... PowerPoint PPT Presentation


Future Market Insights has announced the addition of the “Anti-Viral Drugs Market: Global Industry Analysis and Opportunity Assessment 2016 - 2026" report to their offering.

Download Presentation

Anti-Viral Drugs Market Value Share, Supply Demand, share an...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Anti viral drugs market value share supply demand share and value chain 2016 2026

Global Anti-Viral Drugs

Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

2016-2026

Future Market Insights

www.futuremarketinsights.com

[email protected]


Anti viral drugs market value share supply demand share and value chain 2016 2026

FutureMarket Insights (FMI) is apremier provider of syndicated research reports, custom research reports, andconsulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technologyinputs,valuablegrowthinsights,aerialviewofthecompetitiveframework,andfuturemarkettrends.

Weprovideresearchservicesat aglobalas wellas regionallevel;keyregionsincludeGCC, ASEAN,andBRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

ourclient.

Research Capabilities

Sector Coverage

 Automotive and Transportation

 Electronics, Semiconductor, and ICT

 Retail and Consumer Products

 Industrial Automation and Equipment

 Customized Research

 Syndicated Research

 Investment Research

 Social Media Research

 Chemicals & Materials

 Food and Beverages

 Services and Utilities

 Energy, Mining, Oil, and Gas

Customized

Research

Subscription Information

Syndicated

Research

For detailed subscription information please contact

Hari. T (Sr. Manager -Global Business Development)

Investment

Research

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: [email protected]

Social Media

Research


Anti viral drugs market value share supply demand share and value chain 2016 2026

Report Description

Report Description

Anti-viral drugs are medicines which are used specially for treating viral infections. Most

anti-viral drugs are used for particular viral infections, similar to antibiotics, while a

broad-spectrum anti-viral drug is effective against a varied range of viruses. Antiviral

drugs do not kill their target pathogen, instead they inhibit the development of those

viruses. The global anti-viral drugs market is projected to register a moderate growth rate

in the pharmaceutical market and which is anticipated to increase due to rise in

awareness level, increase in the diseased population and introduction of new drugs with

improved efficacy. Some major patents are reaching their expiry during forecast period,

such as for Combivir, Sustiva, Tenofovir, Tamiflu, Relenza and Telbivudine. The patent

expiries of these blockbuster drugs is expected to trigger generic competition in the

antivirals therapeutics market, which will make the market more competitive. The late

stage pipeline drugs are expected to enter the market, which will positively impact the

market. Most antivirals are considered comparatively harmless to host, and therefore are

used to treat infections. They are different from viricides, which are not used for

medication but can destroy or deactivate virus particles, either outside or inside the

body. The anti-viral drugs are used in the treatment of patients suffering from herpes

viruses, HIV, influenza A and B viruses and the hepatitis B and C viruses.

Request Free Report Sample@

http://www.futuremarketinsights.com/reports/sample/rep-gb-1951


Anti viral drugs market value share supply demand share and value chain 2016 2026

Report Description

Report Description

Anti-viral Drugs Market: Drivers and Restraints

As of October 2013, according to WHO, there were around 35.3 Mn people globally,

infected with HIV. Therefore, increased viral infection incidences is one of the important

factors that drives the anti-viral drugs market growth. Because of the solid R&D activities,

newer and advanced treatments and formulations, such as vaccines, combination

therapy and others, are being introduced in the market. Hence, strong R&D is one of the

crucial factors in the anti-viral drugs market growth. On the other hand, high risk of

failure, high cost of R&D and therapy, and government austerity are some of threats

expected to hinder the growth of market. These are some factors anticipated to fuel

growth of global anti-viral drugs market within the forecast period of 2016-2026.

However, increasing usage of natural products and high cost of developing drugs are the

key challenges faced by the market.

Anti-viral Drugs Market: Segmentation

The global anti-viral drugs market is classified on the basis of product type, end user and

geography.

Based on product type, the global anti-viral drugs market is segmented into the

following:

Hepatitis-C antivirals

HIV antivirals


Anti viral drugs market value share supply demand share and value chain 2016 2026

Report Description

Report Description

Herpes antivirals

Hepatitis-B antivirals

Influenza antivirals

Others (Pneumonia, Flu, etc.)

Based on end user, the global anti-viral drugs market is segmented into the following:

Hospitals

Clinics

Ambulatory Surgical Centers

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1951

Anti-viral Drugs Market: Overview

The generic market of anti-viral drugs is presently dominated by products such as

didanosine, zidovudine, lamivudine and stavudine. The biggest driver of overall anti-viral

drugs market is Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome

(HIV/AIDS) therapeutic sales which accounted for more than half the share of the market

2010. At the end of 2012, 9.7 million people in low-income and middle-income countries

were on antiretroviral treatment (ART). According to WHO, in 2012, number of patients

on ART increased by 1.6 Mn, the largest increase in one year. Nearly four out of five


Anti viral drugs market value share supply demand share and value chain 2016 2026

Report Description

Report Description

people were freshly put on treatment in the sub-Saharan Africa. In 21 African countries

with a high burden of HIV, two out of three people in need are receiving treatment, and

two out of three positive pregnant women are receiving antiretroviral drugs to prevent

HIV transmission to their infants.

Anti-viral Drugs Market: Regional Overview

Region wise, the global anti-viral drugs market is classified into regions namely, North

America, Eastern Europe, Western Europe, Latin America, Japan, Asia-Pacific, Middle East

and Africa. According to WHO, in countries with Major ART scale-up such as Brazil or

China, the death rate among people living with HIV has decreased by 80%. In 2015, in

India the number of people living with HIV were 2.1 Mn and in U.S. the number was

around 1.2 Mn in the year 2013.

Browse Full Report@

http://www.futuremarketinsights.com/reports/anti-viral-drugs-market

Anti-viral Drugs Market: Key Players

Some of the key players in global anti-viral drugs market, which are focusing on general

molecular mechanisms of antiviral drugs rather than therapies for individual viruses,

include Roche, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott, AstraZeneca,

Cipla, Schering-Plough, Johnson & Johnson, Merck & Co and others.


Anti viral drugs market value share supply demand share and value chain 2016 2026

Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

[email protected]

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705


  • Login